miR-27a inhibitors (Centenary Institute of Cancer Medicine and Cell Biology)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemiR-27a inhibitors (Centenary Institute of Cancer Medicine and Cell Biology)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionCadherin 5 modulators
TargetsCadherin 5
Therapy Area/IndicationsWounds and InjuriesIschemiaInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentenary Institute Cancer Medicine & Cell Biology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentenary Institute Cancer Medicine & Cell BiologyBio-Link Australia Pty Ltd
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesIschemiaInflammation

Other Information

ATC CodeN/A
Related LinksN/A